Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Eligible patients were 16 to 50 years of age;~* had received a diagnosed of schizophrenia in accordance with criteria set out in the Diagnostic and Statistical Manual of Mental Disorders-fourth edition (DSM-IV);~* were confirmed to be clinically stable by the investigator (the total score ≤60 on the Positive and Negative Syndrome Scale \[PANSS\] or a decrease of fifty percent from acute period in the total score on PANSS)~* and taken maintenance treatment with any one of the following seven oral antipsychotics:~  * chlorpromazine~ * sulpiride clozapine~ * risperidone~ * olanzapine~ * quetiapine~ * aripiprazole~Exclusion Criteria:~* Patients were excluded if they had received a diagnosis of schizoaffective disorder, mental retardation, or other cognitive disorders;~* had a history of serious adverse reactions to the proposed treatment;~* were pregnant or breastfeeding; or had a serious and unstable medical condition.~* Patients were excluded if they were unable to provide informed consent

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): the comparator arm will only receive one of the seven antipsychotic
- 2 (Type: EXPERIMENTAL): the experimental group will receive one of the seven study drugs combination with psychosocial intervention

Based on this trial design, predict the completion outcome and termination type (if applicable).